An update on adenomyosis in the adolescent

review OA: closed CC0 ⤵ 30 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This review discusses postulated mechanisms, prevalence, and diagnostic and treatment options for adenomyosis, highlighting MRI's role and fertility preservation goals in adolescent management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PURPOSE OF REVIEW: Limited evidence is available on the diagnosis and management of adenomyosis in adolescents. This review highlights the postulated pathophysiologic mechanisms, the prevalence of the condition among adult women and new reports of adenomyosis or adenomyotic cysts occurring in adolescents. Diagnostic criteria as well as treatment options are discussed. RECENT FINDINGS: Very few cases of adenomyosis conditions are reported in the literature, and management schemes differed with regard to medical versus surgical approaches. It is clear from reports in adolescents presenting with severe refractory dysmenorrhea that MRI can help establish a diagnosis of adenomyosis, possibly avoiding or delaying surgery to allow for medical management in some cases. SUMMARY: Adenomyosis may be present during adolescence. Because mechanisms of disease appear to be similar, goals of treatment in the adolescent are toward fertility preservation. Medical management appears to be a good option for certain types of adenomyosis, although surgery may be appropriate in the case of well circumscribed adenomyotic cysts, adenomyomas or noncommunicating horns.

My notes (saved in your browser only)

Condition tags

mesh:D004715adenomyosisdysmenorrhea

MeSH descriptors

Endometriosis Endometriosis Adolescent Aromatase Inhibitors Aromatase Inhibitors Contraceptives, Oral, Combined Contraceptives, Oral, Combined Endometriosis Endometriosis Female Humans Magnetic Resonance Imaging

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Cited by (30)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:17:07.008521+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK